Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country symbols : Seel save search
Seelos Therapeutics to Present a Poster on SLS-005 in Alzheimer's Disease at Neuroscience 2023
Published: 2023-10-27 (Crawled : 19:00) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: 0.38%
H: 2.83%
C: -2.36%
sls-005 disease alzheimer's therapeutics
Seelos Therapeutics Provides Second Quarter 2023 Clinical Update
Published: 2023-08-14 (Crawled : 13:00) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: -2.78%
H: 0.0%
C: -5.0%
update therapeutics
Seelos Therapeutics Doses the First Amyotrophic Lateral Sclerosis (ALS) Patient with SLS-005 in an Expanded Access Program
Published: 2023-04-04 (Crawled : 14:00) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: 0.0%
H: 1.35%
C: 1.35%
sls-005 sclerosis program therapeutics
Seelos Therapeutics Doses First Patients in an Ethnobridging Study with SLS-002 (Intranasal Racemic Ketamine)
Published: 2023-02-06 (Crawled : 15:00) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: -1.44%
H: 6.01%
C: 6.01%
sls-002 therapeutics study
Seelos Therapeutics Releases the Itinerary for its Research and Development Update Conference Call and Webcast to be Held on December 15, 2022
Published: 2022-12-08 (Crawled : 14:20) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: 2.8%
H: 3.64%
C: -1.82%
research conference therapeutics update
Seelos Therapeutics to Hold a Research and Development Update Conference Call and Webcast on December 15, 2022
Published: 2022-11-23 (Crawled : 14:00) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: -0.05%
H: 10.66%
C: 5.72%
research conference therapeutics update
Seelos Therapeutics Doses First Patient in a Registrational Phase II/III study of SLS-005 in Spinocerebellar Ataxia
Published: 2022-10-25 (Crawled : 15:20) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: 1.47%
H: 3.54%
C: 0.55%
sls-005 therapeutics study
Seelos Therapeutics Receives a Notice of Allowance in the U.S. for an Additional Patent for SLS-007
Published: 2022-05-18 (Crawled : 17:00) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: -4.05%
H: 7.76%
C: -1.5%
sls-007 patent therapeutics
Seelos Therapeutics to Participate in the B. Riley Securities' Virtual Neuro and Ophthalmology Conference
Published: 2022-04-22 (Crawled : 16:00) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: 1.3%
H: 1.59%
C: -1.67%
conference therapeutics
Seelos Therapeutics Announces Year-End 2021 Business and Clinical Update
Published: 2022-03-07 (Crawled : 13:30) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: -9.55%
H: 2.53%
C: -3.63%
therapeutics
Seelos Therapeutics Announces Issuance of Composition of Matter Patent in Japan for SLS-007
Published: 2021-12-06 (Crawled : 14:30) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: -0.61%
H: 0.0%
C: 0.0%
patent therapeutics
Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma's Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine
Published: 2021-11-24 (Crawled : 14:00) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: 15.07%
H: 0.71%
C: -10.48%
biopharma acquisition ketamine license liver platform therapeutics
Seelos Therapeutics Announces FDA Acceptance of Investigational New Drug Application and Grant of Fast Track Designation for SLS-005 (IV Trehalose) for the Treatment of Spinocerebellar Ataxia
Published: 2021-11-08 (Crawled : 15:15) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: 0.9%
H: 4.04%
C: 2.69%
new drug fast track designation treatment fda fda acceptance application fast track drug designation
Seelos Therapeutics to Present a Poster on SLS-002 (Intranasal Racemic Ketamine) at the 2021 IASR/AFSP International Summit on Suicide Research
Published: 2021-10-01 (Crawled : 14:00) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: 0.83%
H: 1.03%
C: -2.06%
research ketamine
Seelos Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Published: 2021-05-24 (Crawled : 01:00) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: -0.92%
H: 0.31%
C: -0.31%
offering
Seelos Therapeutics to Participate in the 33rd Annual Roth Conference
Published: 2021-02-17 (Crawled : 15:00) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: 1.5%
H: 1.23%
C: -4.94%
conference therapeutics
Seelos Therapeutics Receives a Notice of Allowance in Japan for SLS-005 (Trehalose)
Published: 2021-01-22 (Crawled : 15:00) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: 2.53%
H: 23.15%
C: 16.4%
Seelos Therapeutics Announced Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-01-05 (Crawled : 16:00) - biospace.com/
SEEL | $0.3271 0.43% 0.09% 380K
|
Health Technology
|
| O: -2.05%
H: 3.85%
C: -0.7%
granted grant
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.